Forte BiosciencesFBRX
13F holders, Q2 2025 (June 30)33holders +4
9new positions
4sold out
1famous investor
$12.95avg. 13F price*
At the end of Q2 2025, 33 institutions reported holding Forte Biosciences Inc. (FBRX) in their 13F filings, up 4 from Q1 2025. 9 opened new positions and 4 sold out. The largest holders were Fred Alger Management, LLC ($20.9M), Janus Henderson Group PLC ($18.3M) and Orbimed Advisors LLC ($15.5M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Forte Biosciences Inc.
- CUSIP
- 34962G208
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $28.1M |
| Exits | 4 | $704K |
All 13F filers, Q1 2025 → Q2 2025: 5,035,769 shares bought and 260,493 shares sold, net +4,775,276 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| Fred Alger Management, LLC | 0.09% | Add +77.8% | 1,618,649 | $20.9M |
| Janus Henderson Group PLC | 0.01% | Add +51.6% | 1,394,852 | $18.3M |
| Orbimed Advisors LLC | 0.39% | Add +101.8% | 1,196,955 | $15.5M |
| Federated Hermes, Inc. | 0.03% | New | 1,072,233 | $13.9M |
| Tybourne Capital Management (hk) Ltd. | 29.45% | Add +26.9% | 786,647 | $10.2M |
| BVF Inc. | 0.27% | Reduce -1.0% | 588,344 | $7.6M |
| Cable Car Capital, LP | 6.00% | Add +127.7% | 500,000 | $6.5M |
| Sphera Funds Management LTD. | 1.67% | New | 495,109 | $6.4M |
| Vanguard Group Inc. | 0.00% | Add +447.4% | 486,919 | $6.3M |
| Ikarian Capital, LLC | 2.04% | Reduce -21.8% | 476,443 | $6.2M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | New | 333,333 | $4.3M |
| Woodline Partners LP | 0.02% | Add +62.1% | 331,987 | $4.3M |
| Heights Capital Management, Inc. | 0.60% | New | 143,033 | $1.8M |
| Millennium Management | 0.00% | Add +393.8% | 72,116 | $932K |
| Perceptive Advisors LLC | 0.03% | New | 68,192 | $882K |
| Geode Capital Management, LLC | 0.00% | Add +6.7% | 64,110 | $829K |
| Boothbay Fund Management, LLC | 0.02% | Reduce -34.3% | 58,637 | $758K |
| Mink Brook Asset Management LLC | 0.44% | New | 38,893 | $503K |
| BlackRock, Inc. | 0.00% | Add +395.3% | 33,695 | $436K |
| Envestnet Asset Management Inc. | 0.00% | New | 18,856 | $244K |
| AlphaQuest LLC | 0.02% | Add +300.7% | 16,897 | $218K |
| Royal Bank of Canada | 0.00% | Add +176.3% | 9,234 | $119K |
| Garde Capital, Inc. | 0.00% | No change | 3,960 | $51K |
| Private Trust Co. NA | 0.00% | Add +357.1% | 192 | $2K |
| Comerica Bank | 0.00% | Add +1.3% | 157 | $2K |
| Morgan Stanley | 0.00% | No change | 151 | $2K |
| Group One Trading LLC | 0.00% | No change | 104 | $1K |
| Bank of America Corp. | 0.00% | Add +19.6% | 55 | $711 |
| SBI Securities Co., Ltd. | 0.00% | No change | 12 | $155 |
| BNP Paribas Financial Markets | 0.00% | No change | 8 | $103 |
| REAP Financial Group, LLC | 0.00% | No change | 3 | $39 |
| Wells Fargo & Company | 0.00% | New | 2 | $26 |
| UBS Group AG | 0.00% | Reduce -99.8% | 1 | $13 |
"% of holder's portfolio" is FBRX's weight in each manager's 13F, not the share of Forte Biosciences Inc. the manager owns.